Does Vitamin D Reduce the Risk of Dementia?

被引:46
作者
Grant, William B. [1 ]
机构
[1] Sunlight Nutr & Hlth Res Ctr SUNARC, San Francisco, CA 94164 USA
关键词
Alzheimer's disease; cardiovascular disease; cathelicidin; periodontal disease; tooth loss; ultraviolet-B; vitamin D; vascular dementia; SERUM 25-HYDROXYVITAMIN-D LEVELS; MILD COGNITIVE IMPAIRMENT; GLYCATION END-PRODUCTS; 3RD NATIONAL-HEALTH; ALZHEIMERS-DISEASE; D DEFICIENCY; DEPRESSIVE SYMPTOMS; METABOLIC SYNDROME; TOOTH EXTRACTIONS; VASCULAR DEMENTIA;
D O I
10.3233/JAD-2009-1024
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The understanding of the role of vitamin D in maintaining optimal health has advanced sharply in the past two decades. There is mounting evidence for beneficial roles for vitamin D in reducing the risk of bone diseases and fractures, many types of cancer, bacterial and viral infections, autoimmune diseases, and cardiovascular diseases. Recently, several reports have also been published regarding the role of vitamin D in neuroprotection. This article develops the hypothesis that vitamin D can reduce the risk of developing dementia, presenting the evidence from observational and laboratory studies. The observational evidence includes that low serum 25-hydroxyvitamin D [25(OH)D] has been associated with increased risk for cardiovascular diseases, diabetes mellitus, depression, dental caries, osteoporosis, and periodontal disease, all of which are either considered risk factors for dementia or have preceded incidence of dementia. The laboratory evidence includes several findings on the role of vitamin D in neuroprotection and reducing inflammation. Although this evidence is supportive, there do not appear to be observational studies of incidence of dementia with respect to prediagnostic serum 25(OH)D or vitamin D supplementation. Such studies now appear to be warranted.
引用
收藏
页码:151 / 159
页数:9
相关论文
共 111 条
[1]   Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice [J].
Aihara, K ;
Azuma, H ;
Akaike, M ;
Ikeda, Y ;
Yamashita, M ;
Sudo, T ;
Hayashi, H ;
Yamada, Y ;
Endoh, F ;
Fujimura, M ;
Yoshida, T ;
Yamaguchi, H ;
Hashizume, S ;
Kato, M ;
Yoshimura, K ;
Yamamoto, Y ;
Kato, S ;
Matsumoto, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (34) :35798-35802
[2]  
Aloia JF, 2007, EPIDEMIOL INFECT, V135, P1095, DOI 10.1017/S0950268807008308
[3]  
Baas D, 2000, GLIA, V31, P59, DOI 10.1002/(SICI)1098-1136(200007)31:1<59::AID-GLIA60>3.0.CO
[4]  
2-Y
[5]   Depressive symptoms, vascular disease, and mild cognitive impairment - Findings from the cardiovascular health study [J].
Barnes, DE ;
Alexopoulos, GS ;
Lopez, OL ;
Williamson, JD ;
Yaffe, K .
ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (03) :273-280
[6]   DIETARY CALCIUM MODIFIES CONCENTRATIONS OF LEAD AND OTHER METALS AND RENAL CALBINDIN IN RATS [J].
BOGDEN, JD ;
GERTNER, SB ;
CHRISTAKOS, S ;
KEMP, FW ;
YANG, ZG ;
KATZ, SR ;
CHU, C .
JOURNAL OF NUTRITION, 1992, 122 (07) :1351-1360
[7]   Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons [J].
Brewer, LD ;
Thibault, V ;
Chen, KC ;
Langub, MC ;
Landfield, PW ;
Porter, NM .
JOURNAL OF NEUROSCIENCE, 2001, 21 (01) :98-108
[8]   Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset [J].
Brookmeyer, R ;
Gray, S ;
Kawas, C .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1998, 88 (09) :1337-1342
[9]   Vitamin D and neurocognitive dysfunction: Preventing "D"ecline? [J].
Buell, Jennifer S. ;
Dawson-Hughes, Bess .
MOLECULAR ASPECTS OF MEDICINE, 2008, 29 (06) :415-422
[10]   Oxidative stress in Alzheimer's disease brain: New insights from redox proteomics [J].
Butterfield, D. Allan ;
Perluigi, Marzia ;
Sultana, Rukhsana .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 545 (01) :39-50